In PNH a C5b-9-dependent pathway leads to membrane-attack-complex-mediated intravascular hemolysis, and a C3-dependent pathway results in deposition of the opsonin C3dg on the erythrocyte, explaining ongoing extravascular hemolysis in patients treated with eculizumab [10]. This evidence concerns the gene C3 and hemolysis.